Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Angle Share Price
  4. Angle Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksAngle Share News (AGL)

Angle Information

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.00
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.50 (8.824%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 17.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 22nd Apr 2021 16:10

Friday 23 April 
Record PLCTrading Statement
XPS Pensions Group PLCTrading Statement
Monday 26 April 
Draper Esprit PLCTrading Statement
International Biotechnology Trust PLCFull Year Results
Pearson PLCQ1 Results
United Oil & Gas PLCFull Year Results
Tuesday 27 April 
Anexo Group PLCFull Year Results
Aveva Group PLCTrading Statement
BP PLCQ1 Results
Egdon Resources PLCHalf Year Results
Focusrite PLCHalf Year Results
Gaming Realms PLCFull Year Results
HSBC Holdings PLCQ1 Results
Inspiration Healthcare Group PLCFull Year Results
IWG PLCQ1 Results
Nostrum Oil & Gas PLCFull Year Results
Property Franchise Group PLCFull Year Results
PZ Cussons PLCQ3 Results
Vivo Energy PLCQ1 Results
Whitbread PLCFull Year Results
Wednesday 28 April 
AB Dynamics PLCHalf Year Results
Brave Bison Group PLCFull Year Results
CRH PLCTrading Statement
French Connection Group PLCFull Year Results
Fresnillo PLCQ1 Production Results
GlaxoSmithKline PLCQ1 Results
HeiQ PLCFull Year Results
Home REIT PLCHalf Year Results
J Sainsbury PLCFull Year Results
Lloyds Banking Group PLCQ1 Results
London Stock Exchange Group PLCTrading Statement
LSL Property Services PLCFull Year Results
Nichols PLCTrading Statement
Pennant International Group PLCFull Year Results
Persimmon PLCTrading Statement
Reckitt Benckiser Group PLCQ1 Results
Renishaw PLCTrading Statement
RPS Group PLCTrading Statement
Tissue Regenix Group PLCFull Year Results
WPP PLCTrading Statement
Yamana Gold IncQ1 Results
Thursday 29 April 
Angle PLCFull Year Results
Appreciate Group PLCTrading Statement
C4X Discovery Holdings PLCHalf Year Results
ConvaTec Group PLCQ1 Results
Evraz PLCQ1 Results
Flutter Entertainment PLCQ1 Results
Glencore PLCQ1 Production Results
Howden Joinery Group PLCTrading Statement
Immotion Group PLCTrading Statement
Inchcape PLCQ1 Results
Indivior PLCQ1 Results
international Personal Finance PLCQ1 Results
Kerry Group PLCQ1 Results
Keystone Law Group PLCFull Year Results
Meggitt PLCQ1 Results
NatWest Group PLCQ1 Results
Proactis Holdings PLCHalf Year Results
Royal Dutch Shell PLCQ1 Results
RTW Venture Fund LtdFull Year Results
Schroders PLCQ1 Results
Shield Therapeutics PLCFull Year Results
Smith & Nephew PLCTrading Statement
St James's Place PLCQ1 Results
Standard Chartered PLCQ1 Results
Synthomer PLCQ1 Results
Unilever PLCQ1 Results
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
Xeros Technology Group PLCFull Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 Feb 2020 15:25

Angle upbeat on German research into 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Monday that University Medical Centre Hamburg-Eppendorf has published results of work undertaken to assess the analytical and clinical performance of 'Parsortix' in multiple metastatic cancer types, with the main emphasis on metastatic breast cancer.

Read more
11 Feb 2020 10:51

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival

Read more
11 Feb 2020 07:41

Angle upbeat on research into Parsortix with melanoma patients

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that a customer, the Edith Cowan University in Perth, Western Australia, has published results of research into the use of its 'Parsortix' system with melanoma patients.

Read more
30 Jan 2020 11:41

Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance

Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance

Read more
23 Jan 2020 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
22 Jan 2020 11:00

Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter

Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter

Read more
7 Nov 2019 13:50

Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma

Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma

Read more
31 Oct 2019 15:38

Angle Submits Positive Test Results For Parsortix System To US FDA

Angle Submits Positive Test Results For Parsortix System To US FDA

Read more
4 Oct 2019 15:17

Angle upbeat on patent grant for prostate cancer blood assessment

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the Queen Mary University of London (QMUL) European patent covering the measurement of the number of megakaryocytes in a patient blood sample as an assessment of the prognosis for prostate cancer has been granted.

Read more
4 Oct 2019 08:58

Angle Notes Queen Mary University's European Cancer Prognosis Patent

Angle Notes Queen Mary University's European Cancer Prognosis Patent

Read more
4 Sep 2019 14:09

Angle Reports Positive Study Results For Parsortix System

(Alliance News) - Angle PLC on Wednesday noted positive results from a study of its Parsortix system in small cell lung cancer.Parsortix is Angle's liquid biopsy technology, meaning it

Read more
29 Aug 2019 10:57

Angle Ovarian Cancer Testing Platform Study Enrols First Patients

(Alliance News) - Liquid biopsy firm Angle PLC said Thursday the first patients for its ovarian cancer test study have been enrolled ahead of anticipated completion early in 2020.The study

Read more
29 Aug 2019 09:12

Angle initiates main phase of ovarian cancer clinical study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the main phase of its 200-patient ovarian cancer clinical verification study has been initiated and the first patient has been enrolled.

Read more
22 Jul 2019 12:53

Angle's Parsortix Used For Analysis Of Circulating Tumor Cells

(Alliance News) - Angle PLC on Monday said one of its leading customers, the Disseminated Cancer Cell Network, has published new results of work done to develop a "robust, reliable and for of

Read more
25 Jun 2019 08:16

Angle looks to strengthen balance sheet and extend runway via placement

(Sharecast News) - Liquid biopsy company Angle will look to raise up £18m at 61.5p per ordinary share through finnCap and WG Partners in order to strengthen its balance sheet and enable the development of key products.

Read more
67891011121314

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.